These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9611904)
21. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data. Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321 [TBL] [Abstract][Full Text] [Related]
22. Screening for colorectal cancer: the accuracy of fecal occult blood. Young GP; St John DJ JAMA; 1993 Jul; 270(4):451-2; author reply 452-3. PubMed ID: 8320780 [No Abstract] [Full Text] [Related]
23. Fecal occult blood testing for colorectal cancer in an ethnically diverse population. Glober GA; Hundahl S; Stucke J; Choy M West J Med; 1994 Oct; 161(4):377-82. PubMed ID: 7817548 [TBL] [Abstract][Full Text] [Related]
24. Comparison of three faecal occult blood tests in the detection of colorectal neoplasia. Hope RL; Chu G; Hope AH; Newcombe RG; Gillespie PE; Williams SJ Gut; 1996 Nov; 39(5):722-5. PubMed ID: 9014773 [TBL] [Abstract][Full Text] [Related]
25. Massive screening for colorectal cancer. A single institution's public commitment. Petrelli NJ; Palmer M; Michalek A; Herrera L; Mink I; Bersani G; Cummings KM Arch Surg; 1990 Aug; 125(8):1049-51. PubMed ID: 2116118 [TBL] [Abstract][Full Text] [Related]
26. Estimates of costs and effects of screening for colorectal cancer in the United States. Byers T; Gorsky R Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342 [TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of screening for colorectal cancer in the general population. Frazier AL; Colditz GA; Fuchs CS; Kuntz KM JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892 [TBL] [Abstract][Full Text] [Related]
28. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350 [TBL] [Abstract][Full Text] [Related]
29. Is routine screening for colorectal cancer justifiable? These gastroenterologists say YES! Early DS; Marshall JB Postgrad Med; 1997 Jul; 102(1):48, 50-52. PubMed ID: 9224479 [TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of colorectal cancer screening methods in Iran. Allameh Z; Davari M; Emami MH Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717 [TBL] [Abstract][Full Text] [Related]
31. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Vijan S; Hwang EW; Hofer TP; Hayward RA Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501 [TBL] [Abstract][Full Text] [Related]
32. Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia. Salkeld G; Young G; Irwig L; Haas M; Glasziou P Aust N Z J Public Health; 1996 Apr; 20(2):138-43. PubMed ID: 8799087 [TBL] [Abstract][Full Text] [Related]
33. Cost benefits of hemoccult screening for colorectal carcinoma. Allison JE; Feldman R Dig Dis Sci; 1985 Sep; 30(9):860-5. PubMed ID: 3928287 [TBL] [Abstract][Full Text] [Related]
34. Screening for colorectal cancer: alternative faecal occult blood tests. Young GP Eur J Gastroenterol Hepatol; 1998 Mar; 10(3):205-12. PubMed ID: 9585022 [TBL] [Abstract][Full Text] [Related]
35. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348 [TBL] [Abstract][Full Text] [Related]